Our International Value Equity strategy delivered a 35.5% return, producing attractive absolute results and outperforming ...
The S&P 500 reached a new record high this week, even momentarily surpassing 7,000 for the first time. Read more here.
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. When it comes to achieving a healthy body weight, some men ...
Zepbound is a prescription drug used to help manage weight loss in certain adults. It can also be used to treat obstructive sleep apenea in adults who are obese. Weight loss with Zepbound may vary ...
The average weight for men in the United States is just under 200 pounds. Diet, activity level, and genetics are key factors that affect your weight. A healthy weight depends on your body type, height ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...
Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album sales. Starting in January, the magazine and authoritative record of music ...
Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug for ...
The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in ...
Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. Iron loft is a hot topic for good reason. It’s one of the first numbers ...
Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results